Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-00-000025
Filing Date
2000-01-18
Accepted
2000-01-18 00:00:00
Documents
1
Group Members
NOVARTIS AGNOVARTIS INCNOVARTIS PHARMACEUTICALS CORPORATION

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D SC 13D/A 10919
  Complete submission text file 0000947871-00-000025.txt   12899
Mailing Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 (619) 658-76
NEUROCRINE BIOSCIENCES INC (Subject) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46089 | Film No.: 508736
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND V8
Business Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND 2128302413
NOVARTIS INC (Filed by) CIK: 0001030617 (see all company filings)